Today's Technical View on Unitedhealth Group, Aetna, AstraZeneca, Oncothyreon, and Zogenix

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130301:nPn3015722

LONDON, March 1, 2013 /PRNewswire/ --

The Healthcare industry is undergoing a major overhaul after the Supreme Court
last year upheld President Obama's Affordable Care Act (ACA). While critics of
the healthcare reform say that it increase costs for the healthcare industry,
proponents of ACA note that the increase in the number of insured individuals
will ultimately benefit the industry. Meanwhile, healthcare companies such as
UnitedHealth Group Inc. (NYSE: UNH), Aetna Inc. (NYSE: AET), AstraZeneca Plc
(NYSE: AZN), Oncothyreon Inc. (NASDAQ: ONTY) and Zogenix Inc. (NASDAQ: ZGNX) are
adapting to the changing market dynamics. On Thursday, Healthcare sector managed
to post modest gains even as the broad market declined. StockCall initiated free
in-depth technical analysis on UNH, AET, AZN, ONTY and XX which are currently
available upon sign up at http://www.stockcall.com/research

Shares of UnitedHealth Group Inc. edged lower in Thursday's trading session,
extending their losses for the week. The stock closed 0.78% lower at $53.45 on
volume of 5.88 million. It has now fallen more than 1.80% this week.
Year-to-date, UnitedHealth's shares are down nearly 1.50%, underperforming the
S&P 500, which has gained more than 6%. The company's shares currently have
support at around $53. The stock has been facing stiff resistance at around
$55.50. Technical indicators for the stock are currently giving strong bearish
signals. Sign up for the free technical analysis on UNH at
http://www.StockCall.com/UNH030113.pdf

Shares of diversified healthcare benefits company, Aetna Inc., also slipped in
Thursday' trading session. The stock closed 0.72% lower at $47.19 on above
average volume of 3.42 million. Despite the pullback yesterday, Aetna's shares
have gained more than 1% in the last three trading sessions. Its shares are
currently trading well above their 200-day moving average. However, recent
volume activity suggests that the market sentiment is bearish on the stock. Its
shares are currently trading on a P/E ratio of 9.85. The stock has a dividend
yield of 1.70. Download the free report on AET by registering at
http://www.StockCall.com/AET030113.pdf

Shares of AstraZeneca Plc ended marginally lower in Thursday's trading session.
The stock closed 0.42% lower at $45.44 on volume of 1.72 million. The stock
has gained 0.58% so far this week. Year-to-date, AstraZeneca Plc shares have
underperformed the broad market, falling nearly 4%. AstraZeneca Plc's MACD has
just crossed the signal line on the upside, which is a bullish signal. The stock
is currently facing resistance at around $46.50. It has support at around $45.
The free report on AZN can be downloaded by signing up now at
http://www.StockCall.com/AZN030113.pdf

Shares of Oncothyreon Inc. edged higher in Thursday's trading session even as
the broad market slipped. The stock closed 1.47% higher at $2.07 on above
average volume of 932,973, extending its gains in the last three trading
sessions to over 10%. Year-to-date, Oncothyreon's shares have gained more than
7.80%. The stock's MACD is currently trading above the signal line, which is a
bullish signal. The stock broke through $2 resistance level this week, which
is another strong bullish signal. Free report on ONTY can be accessed by
registering at http://www.StockCall.com/ONTY030113.pdf

Shares of biotechnology company, Zogenix Inc., rallied in Thursday's trading
session, ending the day 10% higher at $1.87 on above average volume of 9.45
million. The stock has now gained more than 46% in the last three trading
sessions. Zogenix's shares have broken through some key technical levels as a
result of the rally this week. Register with StockCall and download the research
on ZGNX for free at http://www.StockCall.com/ZGNX030113.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the headlines. Sign up
today to talk to our financial analyst at http://www.stockcall.com

SOURCE StockCall.com

William T. Knight, Email: info@stockcall.com, Contact Number: +1-646-396-9857
(9:00 am EST - 01:30 pm EST)